Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Missing Voice Of Patients In Drug-safety Reporting.

E. Basch
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A drug label's “Adverse Reactions” section is based almost entirely on clinicians' impressions of patients' symptoms. Dr. Ethan Basch argues for collecting data directly from patients about symptoms they have while taking a drug.
This paper references



This paper is referenced by
10.1007/978-3-030-20843-1_36
Use of Medications in the Treatment of Aggressive Behavior
L. Charlot (2019)
10.3389/fpsyt.2019.00641
Positive Coping and Resilience as Mediators Between Negative Symptoms and Disability Among Patients With Schizophrenia
Haotian Chen (2019)
10.1056/NEJMc1713349
Recent Developments in Radiotherapy.
D. Citrin (2017)
10.1007/s10555-012-9381-9
Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
C. Bourgier (2012)
10.1186/1471-2407-11-284
The use of erlotinib in daily practice: a study on adherence and patients' experiences
L. Timmers (2011)
10.1007/s12553-020-00510-w
Use of mobile phones for patient self-reporting adverse drug reactions: A pilot study at a tertiary hospital in Rwanda
N. J. Kadima (2020)
10.7939/R34Q7R41C
Patient-reported outcome measures for adverse events: A systematic review and COSMIN evaluation study
Myles Hancock (2017)
10.1111/ene.13025
Correlation of the patient's reported outcome Inflammatory‐RODS with an objective metric in immune‐mediated neuropathies
T. H. Draak (2016)
10.1111/jdv.13214
Differences in patient and physician assessment of a dynamic patient reported outcome tool for chronic pruritus
F. Fritz (2016)
Patient-reported outcomes in the evaluation of toxicity of anticancer treatment
Massimo Di Maio ()
10.1002/mds.27908
HDQLIFE and Neuro‐QoL Physical Function Measures: Responsiveness in Persons with Huntington's Disease
N. Carlozzi (2019)
10.1007/s00432-019-02924-0
Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study
Rui Pedro Marques (2019)
10.1080/14740338.2021.1849134
The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines.
J. Cragg (2020)
10.3768/rtipress.2015.bk.0014.1509
Patient-Reported Outcomes in Performance Measurement
D. Cella (2015)
10.1007/s00520-015-2750-5
Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey
C. Vidall (2015)
10.11226/JAESJSTS.36.4_198
Patient-reported outcome(PRO)データの解析
史郎 樋之津 (2019)
10.1200/JCO.19.01186
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.
N. Yarom (2019)
10.1136/bmjopen-2018-025054
Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol
Nina Deliu (2018)
10.14694/EdBook_AM.2012.32.532
Antiemetic Use in Oncology: Updated Guideline Recommendations from ASCO.
E. Basch (2012)
10.1002/cam4.3483
Association between patient‐initiated emails and overall 2‐year survival in cancer patients undergoing chemotherapy: Evidence from the real‐world setting
J. Coquet (2020)
10.1007/s40264-013-0028-8
Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian Study
Roberto Leone (2013)
10.1177/1740774513475529
The use and reporting of patient-reported outcomes in phase III breast cancer trials
Remy L. Brim (2013)
10.1007/978-3-319-44010-1_8
Patients and Families as Coproducers of Safe and Reliable Outcomes
Helen Haskell (2017)
10.1002/J.0022-0337.2016.80.6.TB06134.X
U.S. Dental School Deans' Views on the Value of Patient-Reported Outcome Measures in Dentistry.
Evan B. Rosen (2016)
10.1016/J.PHCLIN.2011.05.001
Mise en place d’un programme d’éducation thérapeutique des patients traités par corticoïdes dans un service de médecine interne
J. Grangé (2011)
10.4155/CLI.13.108
Measuring symptoms as a critical component of drug development and evaluation in hematological diseases.
L. Williams (2013)
10.1200/JOP.2011.000397
Antiemetics: american society of clinical oncology clinical practice guideline update.
E. Basch (2011)
10.1093/annonc/mdr146
Toxicity burden score: a novel approach to summarize multiple toxic effects.
S. Lee (2012)
Motieven voor het melden van bijwerkingen door patiënten in Nederland
F. V. Hunsel (2012)
10.1016/j.brachy.2018.09.005
Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer.
J. Conway (2019)
10.1016/j.schres.2014.07.027
Wellness within illness: Happiness in schizophrenia
B. Palmer (2014)
10.3802/jgo.2018.29.e81
A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer
M. Wilson (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar